홈 › 급성 골수성 백혈병 › 오하이오 › Cleveland
OH Cleveland의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 20개가 Cleveland 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Case Western Reserve University, Cleveland
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
피험자 모집 중3상
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
피험자 모집 중2상
- Case Western Reserve University, Cleveland
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Case Western Reserve University, Cleveland
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Case Western Reserve University, Cleveland
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
피험자 모집 중3상
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
피험자 모집 중2상
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
피험자 모집 중1/2상
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
피험자 모집 중3상
- Rainbow Babies and Childrens Hospital, Cleveland
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
피험자 모집 중1상
- Cleveland Clinic, Cleveland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
피험자 모집 중1/2상
- Rainbow Babies and Childrens Hospital, Cleveland
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- UH Seidman Cancer Center, Cleveland
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
피험자 모집 중2/3상
- University Hospitals Cleveland Medical Center, Cleveland
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
피험자 모집 중3상
- The Ohio State University Comprehensive Cancer Center (OSUCCC), Cleveland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
피험자 모집 중관찰 연구
- University Hospitals Case Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
피험자 모집 중1상
- Case Western Reserve University, Cleveland
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
피험자 모집 중1/2상
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
- University Hospitals Seidman Cancer, Case Comprehensive Cancer Center, Cleveland
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
피험자 모집 중1상
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Institute, Cleveland
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
피험자 모집 중1상
- Cleveland Clinic Cancer Center, Cleveland
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
피험자 모집 중관찰 연구
- University Hospitals Seidman Cancer Center, Cleveland
다른 도시의 급성 골수성 백혈병 시험
- Houston, TX연구 85개
- New York City, NY연구 51개
- Boston, MA연구 44개
- Baldwin Park, CA연구 40개
- Seattle, WA연구 40개
- Columbus, OH연구 35개
- Philadelphia, PA연구 34개
- Durham, NC연구 33개
- Atlanta, GA연구 30개
- Tampa, FL연구 29개
- Chicago, IL연구 26개
- Portland, OR연구 25개
Cleveland의 다른 연구
- 비소세포폐암연구 43개
- 암 (전체)연구 36개
- 유방암연구 35개
- 전립선암연구 34개
- 심부전연구 33개
- 전이성 암연구 30개
- 난소암연구 30개
- 폐암연구 26개
- 대장직장암연구 24개
- 심혈관 질환연구 22개
- 자궁내막암연구 20개
- 크론병연구 19개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.